Due to the limited samples that could be obtained, we could not quantify differences between the human and GEMM primary tumors however they qualitatively appeared to have similar numbers of CD45+, GFAP+, and CD8+ cells, while the human primary tumor appeared to have more CD163 expression than the GEMM. The gene discussed is PTPRC; the disease is neoplasm.